Oxfendazole
AntiparasiticsA benzimidazole anthelmintic (an active metabolite of fenbendazole). It binds to the parasite's β-tubulin, preventing microtubule formation and disrupting its metabolism, causing death.
Drug class
Antiparasitics
Registered species
2
Recorded effects
0
Related products
1
Pharmacological information
A class-level scientific overview for general reference — no doses. The ultimate reference is always the locally approved product leaflet and consultation with a veterinarian.
Mechanism of action
A benzimidazole anthelmintic (an active metabolite of fenbendazole). It binds to the parasite's β-tubulin, preventing microtubule formation and disrupting its metabolism, causing death.
Indications
- Gastrointestinal and lung roundworms
- Some susceptible tapeworms
Contraindications & warnings
- Caution in early pregnancy in some species per the label
- Adherence to withdrawal periods in food animals
Drug interactions
- No major documented drug interactions at the class level
Withdrawal periods
Note: Source: UK Veterinary Medicines Directorate (VMD). The figures are a guidance reference that may differ from the product registered in your country — always verify the locally approved leaflet and consult a veterinarian before slaughter or consuming products.
Bovex 2.265% w/v Oral Suspension for Cattle and Sheep
Oral suspension · Chanelle Pharmaceuticals Manufacturing Ltd
| Species | Meat | Milk | Eggs |
|---|---|---|---|
| Cattle | 19 days | 84 hours | — |
| Sheep | 24 days | — | — |
Recorded adverse effects
openFDA veterinary reports — the numbers are report counts, not a severity rate.
No adverse-effect data recorded for this ingredient yet.
Related products
Sources
- •Withdrawal periods: UK Veterinary Medicines Directorate (VMD).
- •European Medicines Agency (EMA) — Veterinary medicines
- •Merck Veterinary Manual — Pharmacology
- •Always verify the locally approved leaflet and consult a veterinarian.